Evidence map›Paper›PMID 35782897›Full record

ArticleOncology letters2022

Elevated AKIP1 expression is associated with tumor invasion, shorter survival time and decreased chemosensitivity in endometrial carcinoma.

Aili Li, Aijing Li, Xiangpeng Gao, Tongyan Zhang, Zhiling Ma, Yalin Xiao, Fei Zhao

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Aili LiDepartment of Gynecology, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Aijing LiDepartment of Gynecology, Renqiu People's Hospital, Cangzhou, Hebei 062550, P.R. China.
Xiangpeng GaoSchool of Clinical Medicine, Graduate School of Hebei University, Baoding, Hebei 071002, P.R. China.
Tongyan ZhangDepartment of Gynecology, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Zhiling MaDepartment of Gynecology, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Yalin XiaoDepartment of Gynecology, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Fei ZhaoDepartment of Surgery, Handan Central Hospital, Handan, Hebei 056001, P.R. China.
Handan College · CNHebei University · CNPeople's Hospital of Cangzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A-kinase-interacting protein 1 (AKIP1), as a recently discovered oncoprotein, promotes cell malignant behaviors in gynecological malignancies. To the best of our knowledge, no study reports its clinical value in patients with endometrial carcinoma. The present study aimed to explore the association between AKIP1 expression and clinical features and survival in patients with endometrial carcinoma, and to assess the effect of AKIP1 knockdown on the regulation of chemosensitivity

Indexed as

AKIP1chemosensitivityclinicopathological featuresendometrial carcinomasurvival

Identifiers

PMID35782897
PMCPMC9247666
OpenAlexW4283156088

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.